| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.35▼ | 3.33▲ | 3.32▲ | 3.33▲ | 3.19▲ |
| MA10 | 3.34▲ | 3.32▲ | 3.34▼ | 3.23▲ | 3.05▲ |
| MA20 | 3.32▲ | 3.35▼ | 3.35▼ | 3.13▲ | 2.96▲ |
| MA50 | 3.32▲ | 3.32▲ | 3.24▲ | 3.04▲ | 3.66▼ |
| MA100 | 3.34▼ | 3.23▲ | 3.18▲ | 2.97▲ | 4.73▼ |
| MA200 | 3.35▼ | 3.17▲ | 3.08▲ | 3.63▼ | 5.94▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.004▼ | -0.011▼ | 0.024▲ | 0.109▲ |
| RSI | 59.283▲ | 51.084▲ | 55.759▲ | 60.618▲ | 52.299▲ |
| STOCH | 81.779▲ | 38.797 | 19.390▼ | 70.434 | 64.996 |
| WILL %R | -36.364 | -62.500 | -79.545▼ | -31.746 | -20.412▲ |
| CCI | 71.515 | 42.312 | -31.500 | 111.573▲ | 164.318▲ |
|
Monday, September 07, 2026 05:00 PM
On August 12, Altimmune (NASDAQ:ALT) reported second quarter results that read less like a routine earnings update and more like a status check on three separate diseases at the same time. The ...
|
|
Tuesday, July 28, 2026 05:23 AM
Altimmune Inc. (NASDAQ:ALT) shares climbed 18% on Tuesday after the biotechnology company reported positive topline data from its Phase 2 RECLAIM study evaluating pemvidutide as a treatment for ...
|
|
Wednesday, June 17, 2026 04:16 AM
Altimmune, Inc. (NASDAQ:ALT) is one of the small-cap stocks with potential to rise 1000 percent. The company’s lead drug candidate, pemvidutide, is being developed for MASH, a serious liver disease ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/09/26 | 3.35 | 3.425 | 3.291 | 3.35 | 3,069,900 |
| 08/09/26 | 3.46 | 3.55 | 3.34 | 3.36 | 3,588,400 |
| 04/09/26 | 3.28 | 3.43 | 3.25 | 3.42 | 4,867,100 |
| 03/09/26 | 3.305 | 3.31 | 3.195 | 3.22 | 2,258,371 |
| 02/09/26 | 3.10 | 3.34 | 3.10 | 3.28 | 7,470,000 |
| 01/09/26 | 3.07 | 3.095 | 3.02 | 3.09 | 2,335,731 |
| 31/08/26 | 3.08 | 3.135 | 3.06 | 3.11 | 2,215,531 |
| 28/08/26 | 3.21 | 3.23 | 3.0601 | 3.11 | 3,187,399 |
| 27/08/26 | 3.19 | 3.25 | 3.1301 | 3.24 | 2,244,105 |
| 26/08/26 | 3.19 | 3.19 | 3.09 | 3.15 | 4,044,934 |
|
|
||||
|
|
||||
|
|